Helen Ye

548 citations
7 papers · 346 indexed · h-index 5
Topics
Peptidase Inhibition and Analysis (2 papers)Acute Myeloid Leukemia Research (1 paper)Synthesis and biological activity (1 paper)
Partner nations
United StatesCanada

In The Last Decade

Helen Ye

7 papers receiving 335 citations

Peers

Helen Ye
Comparison fields: 5 of 56
  • Molecular Biology 209
  • Pulmonary and Respiratory Medicine 95
  • Oncology 73
  • Hematology 54
  • Cancer Research 45
Replace Rhyannon Spangler with:
Rhyannon Spangler United States
Robert Cozens Switzerland
Heather Knowles United States
Estelle Daudigeos‐Dubus France
Jae Hwi Song South Korea
Changwen Jing China
Matthieu Broussas France
Michael W. Potter United States
Jodi L. Kroeger United States
Misato Ito Japan
Helen Ye relative to Rhyannon Spangler United States Rhyannon Spangler's profile →
Citations per field
00.5×2.8×
Rhyannon Spangler · 1×
Citations per year

Countries citing papers authored by Helen Ye

Since Specialization
Citations

This map shows the geographic impact of Helen Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Ye more than expected).

Fields of papers citing papers by Helen Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Ye. The network helps show where Helen Ye may publish in the future.

Co-authorship network of co-authors of Helen Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Ye. A scholar is included among the top collaborators of Helen Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Ye. Helen Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1
An innovative vascular access option for haemodialysis
1
2
CHIR-265, a novel inhibitor that targets B-Raf and VEGFR, shows efficacy in a broad range of preclinical models
10
3 22
4 1
5 148
6 95
7 69

About Helen Ye

Helen Ye is a scholar working on Hematology, Nephrology and Emergency Medical Services, having authored 7 papers that have together received 346 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Acute Myeloid Leukemia Research (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Hematology (54 citations), Genetics (40 citations) and Molecular Biology (209 citations). Helen Ye has collaborated with scholars based in United States and Canada. Frequent co-authors include Carla Heise, Evelyn N. Garrett, Sharon L. Aukerman, Arnold B. Gelb, Daniel L. Menezes, Alex L. Harris, Emil Samara, Jayesh Vora, Sang Hoon Lee and Lori G. Rochelle. Their work appears in journals such as Blood, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026